Status:
COMPLETED
Virtual Reality Compared to Screen Based Engagement on Mood
Lead Sponsor:
Palo Alto University
Conditions:
Virtual Reality
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
Depression has a lifetime prevalence rate of 20.6% and has one of the highest prevalence rates of mental health disorders. Major depressive disorder can lead to higher costs of living for individuals ...
Detailed Description
Once participants consent, they will complete the three demographic questions and their familiarity with virtual reality. Participants will also complete the Patient Health Questionnaire-8(PHQ-8), Aff...
Eligibility Criteria
Inclusion
- Any individuals who are a general adult population (18-64), be able to read English, and United States Residents. Individuals must be able to read English as all surveys are provided in English.
Exclusion
- Individuals who are not part of the general adult population
- Individuals who can not read English
- Individuals who are not United States residents
- Individuals who endorse a history of motion sickness, nausea, migraines, headaches, balance issues, dizziness, epilepsy, neurological conditions where visual stimuli may trigger seizures or other issues, pregnancy, recent concussions, recent illness, recent contagious condition, or other conditions where dizziness, nausea, or headaches are present
Key Trial Info
Start Date :
January 29 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT05249582
Start Date
January 29 2022
End Date
September 1 2022
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Palo Alto University
Los Altos, California, United States, 94022